Daniel Santamaría del Ángel
National Autonomous University of Mexico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Santamaría del Ángel.
The Journal of Steroid Biochemistry and Molecular Biology | 2005
David Calderón Guzmán; Gerardo Barragán Mejía; Ivonne R. Espítia Vázquez; Ernestina Hernández García; Daniel Santamaría del Ángel; Hugo Juárez Olguín
The purpose of the present study was to evaluate the effect of 4-pregnen-17-hydroxy-3-one (A) and two steroids homologues: 3beta-acetoxy-5,16-pregnadien-20-one (B) and 3beta-acetoxy-16alpha-17alpha-epoxy-4-pregnen-20-one (C). Male Wistar rats were treated with o-cresol combined (A, B or C) steroids. Lipid peroxidation status as result of measurement reactive substances to thiobarbituric acid (TBARS) as well as serotonin (5-HT) and its precursor 5-hydroxytryptophan (5-HTP) were measured. The prostate glands were weighed, the 5alpha-reductase activity was determined. The animals treated with A, B, and C steroids showed a slight increase in both 5alpha-reductase activity and prostate size. 5-HT and 5-HTP levels did not change significantly, and TBARS showed an increase in the group treated with B steroid and a decrease in the A steroid group with significant differences in both groups (p<0.05) versus control group. Results suggest that A steroid reduces TBARS in rat brain, perhaps as a result of the interaction between the testosterone unsaturated carbons and OH(-) groups with free radicals.
Archives of Medical Research | 2002
M.Gerardo Barragán-Mejı́a; Luis Castilla-Serna; David Calderón-Guzmán; J.Luis Hernández-Islas; Norma Angélica Labra-Ruíz; R.Antonio Rodrı́guez-Pérez; Daniel Santamaría del Ángel
BACKGROUND Ozone is an environmental pollutant that has widely documented deleterious effects on exposed organisms. In Mexico City, this pollutant frequently reaches concentrations that surpass safe health limits. In addition, it has been reported that the prevalence of malnutrition remains high in our childhood population. This experiment was carried out to determine whether malnutrition is a factor contributing to an increase in the risk of damage associated with ozone exposure. METHODS Using an experimental animal model, 21-day-old rats fed normally or with induced malnutrition were subchronically exposed to 0.5 ppm of ozone or fresh air, respectively, for 30 days. At the end of this period and using HPLC, serotonin concentrations were measured in four areas of the brain: cortex, hemispheres, cerebellum, and medulla oblongata. RESULTS Malnourished animals had a significant weight deficit beginning at 28 days with respect to well-fed animals. Among the well-fed animals, this phenomenon is seen at 35 days in exposed and non-exposed animals. In the four regions of the brain, malnourished animals show low serotonin concentrations with respect to well-nourished animals. In the cerebellum, there was an interaction between the nutritional factor and ozone exposure, while in the medulla oblongata both factors acted independently. CONCLUSIONS Our results suggest a multiplicative effect from the nutritional factor and ozone exposure in the changes observed concerning serotonergic metabolism.
Biomedicine & Pharmacotherapy | 2016
Daniel Santamaría del Ángel; Norma Angélica Labra-Ruíz; Mercedes Edna García-Cruz; David Calderón-Guzmán; Armando Valenzuela-Peraza; Hugo Juárez-Olguín
UNLABELLED The aim of this work was to compare the effects of catechin (CAT), epicatechin (EPI) and N-ω-l-nitroarginine (L-NARG) on different endpoints of oxidative stress induced by quinolinic acid (QUIN) in a simple tissue preparation, rat striatal slices - with particular emphasis in the glutathione system - in order to provide revealing information on the antioxidant efficacy of these agents in an excitotoxic model. METHODS Rat striatal slices were incubated for 1h in the presence of 100 μM QUIN and/or 85 μM CAT or EPI, or 100 μM L-NARG. Lipid peroxidation (LP) and the levels of reduced and oxidized glutathione (GSH and GSSG) were determined. RESULTS The three agents tested completely blocked the QUIN-induced lipid peroxidation and recovered the QUIN-induced altered GSH/GSSG balance. No statistical differences were detected among the protective effects exerted by these antioxidants, suggesting similar efficacy and common antioxidant mechanisms. The antioxidant properties exhibited by these molecules on the excitotoxic model tested herein support an active role of glutathione and prompt their use as therapeutic tools in models of neurodegenerative disorders.
Basic & Clinical Pharmacology & Toxicology | 2012
David Calderón Guzmán; Ernestina Hernández García; Gerardo Barragán Mejía; Hugo Juárez Olguín; Francisca Trujillo Jiménez; Erick Buendía Soto; Daniel Santamaría del Ángel; Liliana Carmona Aparicio
A number of drugs, like sibutramine, which are used clinically in weight control, act on serotonergic metabolism. However, their relation with zinc and free radical (FR) production in central nervous system remains unknown. This study aimed to evaluate the effect of sibutramine and zinc on FR production. Female Wistar rats (about 250 g) were used in this study. The animals received 400 μg/kg of zinc and 10 mg/kg of sibutramine intraperitoneally every 36 hr for 15 days. At the end of the study, the rats were killed and their brains used for the measurement of lipid peroxidation thiobarbituric acid-reactive substances (TBARS), reduced glutathione (GSH), hydrogen peroxide (H(2) O(2) ), calcium and 5-hydroxyindole acetic acid (5-HIAA) levels, all by means of validated methods. Corporal weight and food consumption were found to be decreased in the zinc/sibutramine group. TBARS decreased in cortex, hemispheres and medulla oblongata. GSH decreased in cortex, hemispheres and cerebellum in the sibutramine group. Zinc given alone and in combination with sibutramine decreased H(2) O(2) concentration in cortex, hemispheres and cerebellum but increased calcium and 5-HIAA concentration in all brain regions. Our results suggest that sibutramine and zinc are associated with weight loss, an effect that was more pronounced in the group treated with both drugs. Reduction in oxidative stress may be involved in these effects.
Archives of Pharmacal Research | 2010
David Calderón Guzmán; Ernestina Hernández García; Norma Osnaya Brizuela; Francisca Trujillo Jiménez; Gerardo Barragán Mejía; Hugo Juárez Olguín; Daniel Santamaría del Ángel; Nuñez A. Elvira; Liliana Carmona Aparicio
The effect that osteltamivir has on the metabolism of catecholamines and oxidative damage in the brains of young patients remains unclear. The purpose of this study was to measure the effects of oseltamivir, in the presence of oligoelements, on biogenic amines and select oxidative biomarkers in the brains of uninfected, young rats under normal conditions. The study was conducted using male Wistar rats intraperitoneally treated for three days with either a control dose of 0.9 % NaCl, oseltamivir (50 mg/kg), oligoelements (50 μL/rat), or oseltamivir (50 mg/kg) and oligoelements (50 μL/rat). The brain tissue extracted from the treated rats was used to determine the concentrations of adrenaline, noradrenaline, and dopamine, as well as the levels of GSH, lipid peroxidation, and ATPase activity. An increase in the concentration of adrenaline and noradrenaline and in the level of GSH in the group treated with oligoelements (p < 0.001) was observed, while the group treated with oseltamivir and oligoelements, the levels of dopamine increased (p < 0.001), and in the groups treated with oligoelements alone or combination with oseltamivir a decrease in lipid peroxidation was observed (p < 0.001). The results of this study suggest that the consumption of oseltamivir and oligoelements induce biphasic changes in the metabolism of catecholamines; thereby, inducing a protective mechanism against oxidative damage in the brains of young rats.
Nutricion Hospitalaria | 2018
Ernestina Hernández García; Norma Osnaya Brizuela; Armando Valenzuela Peraza; David Calderón Guzmán; Maribel Ortiz Herrera; Hugo Juárez Olguín; Gerardo Barragán Mejía; Daniel Santamaría del Ángel; Alberto Rojas Ochoa
OBJECTIVE The aim of this study was to evaluate the effect of splenda and stevia on dopamine and 5-HIAA levels, and some biomarkers of oxidative stress in the presence of cytarabine. METHODS Forty-eight young male Wistar rats each with a weight of 80 g (four weeks of age), distributed in six groups of eight animals each, were treated as follows: group 1, control (NaCl 0.9% vehicle); group 2, cytarabine (0.6 g/kg); group 3, stevia (0.6 g/kg); group 4, cytarabine + stevia; group 5, splenda; and group 6, cytarabine + splenda. Cytarabine was given intravenously (IV) while stevia and splenda were administered orally for five days, using orogastric tube. At the end of treatment, the animals were sacrificed and glucose levels in blood were measured. The brains were dissected for histological analysis and homogenated to measure levels of dopamine, lipid peroxidation (TBARS), serotonin metabolite (5-HIAA), Na+, K+ ATPase activity, and glutathione (GSH), using validated methods. RESULTS Sweeteners increased the glucose in animals that received cytarabine. Dopamine increased in cortex and decreased in striatum of animals that received stevia alone and combined with cytarabine. 5-HIAA decreased in striatum and cerebellum/medulla oblongata of animals that received sweeteners and cytarabine alone or combined. GSH increased in animals that received sweeteners and decreased with cytarabine. Lipoperoxidation decreased in groups that received sweeteners and cytarabine. Histopathological changes revealed marked degeneration of neuronal cells in animals treated with cytarabine. CONCLUSION These results show that sweeteners as stevia or splenda may lead to the onset of unfavorable changes in dopamine and 5-HIAA. Antioxidant effects may be involved. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with cytarabine.
Endocrine‚ Metabolic & Immune Disorders-Drug Targets | 2014
David Calderón Guzmán; Eugene Bratoeff; Aylin Viviana Silva Ortiz; Ernestina Hernández García; Norma Osnaya Brizuela; Gerardo Barragán Mejía; Hugo Juárez Olguín; Daniel Santamaría del Ángel; Israel M. Cruz
UNLABELLED Flutamide is a drug used in the treatment of androgen-dependent disorders. However, this treatment is usually accompanied by some adverse side effects. The aim of this work was to analyse the effect of flutamide and to compare this effect with that of a synthetic steroid - 3β-propionyloxy-5-androsten-17-one (PPA) - on levels of dopamine and some oxidative stress markers. For this, thirty-six male young Wistar rats (65g) were recruited and divided into 6 groups. The groups were then treated as follows: Group 1 (control), dimethyl sulfoxide (DMSO); group 2, flutamide (4 mg/kg); group 3, PPA; group 4, DMSO + fructose; group 5, flutamide + fructose; and group 6, PPA + fructose. The treatments were administered intraperitoneally at a daily dose of 4 mg/kg for 10 days. In the last day of treatment, blood samples were obtained and used to assess the levels of glucose and cholesterol. The animals were then sacrificed and their prostate gland and brains were obtained for measurement of 5α-reductase, glutathione (GSH), calcium, H2O2, and dopamine in cortex, hemispheres, and medulla/oblongata, using previously validated methods. RESULTS Dopamine levels decreased while GSH increased significantly in cortex and hemispheres of animals that received PPA plus fructose. Also in the same group, GSH decreased in cerebellum/medulla oblongata when compared with control group. Peroxidation decreased significantly in all tissues of the groups, while ATPase activity witnessed a significant decrease in cortex and an increase in hemispheres of animal groups treated with flutamide and PPA both in combination with fructose. CONCLUSION The steroid, 3β-propionyloxy-5-androsten-17-one, may in part act as a neuroprotector mediated by the increase of GSH and decrease of H2O2. Besides, imbalance in steroid homeostasis may alter the metabolism of dopamine.
Archives of Medical Research | 2004
David Calderón-Guzmán; José Luis Hernández-Islas; Ivonne Espitia-Vázquez; Gerardo Barragán-Mejía; Ernestina Hernández-García; Daniel Santamaría del Ángel; Hugo Juárez-Olguín
Regulatory Toxicology and Pharmacology | 2005
David Calderón-Guzmán; José Luis Hernández-Islas; Ivonne R. Espítia Vázquez; Gerardo Barragán-Mejía; Ernestina Hernández-García; Daniel Santamaría del Ángel; Hugo Juárez-Olguín
Biomedicine & Aging Pathology | 2011
Ernestina Hernández García; David Calderón Guzmán; Hugo Juárez Olguín; Francisca Trujillo Jiménez; Elvira Nuñez Acosta; Francisco Pierdant Rioja; Gerardo Barragán Mejía; Norma Labra Ruíz; Daniel Santamaría del Ángel